VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 34 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,287,421 | -35.5% | 3,082,622 | 0.0% | 4.98% | -57.6% |
| Q2 2023 | $73,335,577 | +6.8% | 3,082,622 | +14.2% | 11.73% | -12.6% |
| Q1 2023 | $68,684,566 | -12.9% | 2,699,865 | 0.0% | 13.41% | +0.9% |
| Q4 2022 | $78,863,057 | +80.5% | 2,699,865 | +26.7% | 13.28% | +97.0% |
| Q3 2022 | $43,693,000 | +103.8% | 2,130,308 | +15.0% | 6.74% | +59.7% |
| Q2 2022 | $21,438,000 | -37.4% | 1,852,919 | 0.0% | 4.22% | -23.9% |
| Q1 2022 | $34,260,000 | -6.5% | 1,852,919 | 0.0% | 5.55% | +10.8% |
| Q4 2021 | $36,632,000 | +11311.8% | 1,852,919 | +9404.6% | 5.01% | +12114.6% |
| Q3 2021 | $321,000 | -10.1% | 19,495 | 0.0% | 0.04% | -4.7% |
| Q2 2021 | $357,000 | +9.5% | 19,495 | 0.0% | 0.04% | +22.9% |
| Q1 2021 | $326,000 | +1.6% | 19,495 | 0.0% | 0.04% | -25.5% |
| Q4 2020 | $321,000 | – | 19,495 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |